LDS/Medical Tests/HLA Class I Typing, Antigen or Genotyping

HLA Class I Typing, Antigen or Genotyping

The human leukocyte antigens (HLA) are glycoproteins (similar to immunoglobulins) produced by six closely linked loci of the major histocompatibiltity complex class I (HLA-A, B, C) and class II (DR, DQ, and DP) located on the short arm of chromosome 6. They are usually inherited as a haplotype (inherited from one parent). HLA antigens are present on the surface of all cells in the body and serve as self-identification antigens. Therefore, their main role is the recognition of foreign antigens. Because transplant tissues and organs also express HLA on their surface and differ from the recipient’s HLA antigens, donor’s HLA antigens will be recognized as foreign antigens. Therefore, HLA testing identifies the major HLA genes and corresponding antigens of the donor and the recipients that are present on the surface of their cells. HLA genes and the corresponding antigens of the donor should match the recipient's as closely as possible for a transplant to be successful or for the tissue to not be rejected by the recipient's immune system.

HLA typing is usually performed for transplantation candidates (solid organ transplants such as kidney and liver transplants), typing for hematopoietic stem cell transplantation (HSC) and blood product matching (e.g., platelets), typing as an aid in the diagnosis of HLA-associated diseases such as those associated with HLA-B27 (ankylosing spondylitis) and in paternity testing. The previous "gold standard" technique for HLA typing was the complement-dependent cytotoxicity test. This is a complement-mediated serologic assay in which antiserum containing specific anti-HLA antibodies is added to peripheral blood lymphocytes. Cell death indicates that the lymphocytes carried the specific targeted antigen. HLA-A, B, and C types are determined in this manner. The HLA-D locus (DR or D-related) is determined by Mixed Lymphocyte Culture.

DNA-based methods for HLA genotyping have now replaced traditional HLA testing based on serologic assays. Both methods will screen for matching where genes or antigens of transplant recipients are compared to those of genes or antigens of the potential donors. The greater the number of matches between recipients and the donor, the better chances of successful transplant and less chance of rejection. DNA typing is most important for Bone Marrow transplantation because an accurate typing may mean the difference between life and death.

  • Evaluation of potential donors and transplant candidates for compatibility
  • For paternity and forensic testing
The greater the number of matches between recipient and donor, the more likely a successful transplant procedure and the a reduced chance of rejection.

Identification of specific HLA antigens class I and class II (The greater the number of matches the better chance of a successful transplant)

DNA Sequence-specific oligonucleotide probes (SSOP), Sequence-specific oligonucleotide primers (SSP), and direct Sequencing, Genotyping by Flow cytometry.

Whole Blood EDTA (Lavender) or ACD (Yellow). 

Stability

  • Ambient: 7 days
  • Refrigerated: 7 days
  • Frozen: Unacceptable
HLA-B27, Mixed Lymphocyte Culture, Tissue Typing, White Blood Cell Count, Blood Typing, Antibody Tests, CMV viral load, EBV viral load, BK virus.
5-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login